ProMIS Neurosciences (PMN) EPS (Basic) Growth (3y) (2024 - 2026)
ProMIS Neurosciences (PMN) EPS (Basic) Growth (3y) (2024 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EPS (Basic) Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.82 Bn | 131.97 Bn | 2.84 Bn | 6.85% |
| 2 | Regeneron Pharmaceuticals | 86.70 Bn | 78.71 Bn | 3.93 Bn | 11.71% |
| 3 | Argenx Se | 65.27 Bn | 60.09 Bn | 1.37 Bn | 64.84% |
| 4 | Moderna | 59.18 Bn | 54.04 Bn | 52.00 Mn | 18.44% |
| 5 | BeOne Medicines | 42.11 Bn | 37.01 Bn | 1.53 Bn | 37.21% |
| 6 | Alnylam Pharmaceuticals | 31.80 Bn | 28.49 Bn | 992.69 Mn | 36.73% |
| 7 | BioNTech SE | 28.14 Bn | 9.75 Bn | 668.28 Mn | -26.87% |
| 8 | Insmed | 27.53 Bn | 26.37 Bn | 358.27 Mn | 67.51% |
| 9 | Royalty Pharma | 27.26 Bn | 26.42 Bn | - | -38.31% |
| 10 | ProMIS Neurosciences | 134.39 Mn | 80.93 Mn | - | 42.47% |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 42.47% |
| Mar 31, 2026 | 55.62% |
| Dec 31, 2025 | -27.31% |
| Sep 30, 2025 | 34.08% |
| Jun 30, 2025 | 8.70% |
| Mar 31, 2025 | 10.20% |
| Dec 31, 2024 | -26.51% |
| Sep 30, 2024 | 16.12% |
| Jun 30, 2024 | 18.26% |